Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ERIS LIFESCIENCES Gains 5%; BSE HEALTHCARE Index Down 0.3%
Thu, 3 Oct 9:48

ERIS LIFESCIENCES Gains 5%; BSE HEALTHCARE Index Down 0.3%Image source: DNY59/www.istockphoto.com

ERIS LIFESCIENCES share price has zoomed 5% and is presently trading at Rs 1,370.6.

Meanwhile, the BSE HEALTHCARE index is at 44,113.3 (down 0.3%).

Among the top gainers in the BSE HEALTHCARE index today are ALEMBIC PHARMA (up 2.4%) and GRANULES INDIA (up 2.1%).

KIMS (down 6.2%) and FORTIS HEALTHCARE (down 3.2%) are among the top losers today.

Over the last one year, ERIS LIFESCIENCES has moved up from Rs 908.7 to Rs 1,370.6, registering a gain of Rs 461.9 (up 50.8%).

On the other hand, the BSE HEALTHCARE index has moved up from 28,428.9 to 44,113.3, registering a gain of 55.2% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 164.4%), SUVEN PHARMACEUTICALS (up 109.3%) and Glenmark Pharma (up 98.5%).

Must See: These Segments are Witnessing Incredible Growth with Modi's Push

What About the Benchmark Indices?

The BSE Sensex is at 83,714.3 (down 0.7%).

The top losers among the BSE Sensex today are Asian Paints (down 2.2%) and Tata Motors (down 2.0%). The most traded stocks in the BSE Sensex are HDFC Bank and Tata Steel.

In the meantime, NSE Nifty is at 25,616.8 (down 0.7%). BPCL and Eicher Motor are among the top losers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 65,512.1 to 83,714.3, registering a gain of 18,202.2 points (up 27.8%).

ERIS LIFESCIENCES Financial Update...

ERIS LIFESCIENCES net profit fell 4.5% YoY to Rs 894 million for the quarter ended June 2024, compared to a profit of Rs 937 million a year ago. Net sales rose 54.2% to Rs 7,197 million during the period as against Rs 4,666 million in April-June 2023.

For the year ended March 2024, ERIS LIFESCIENCES reported 6.1% increase in net profit to Rs 3,971 million compared to net profit of Rs 3,742 million during FY23. Revenue of the company grew 19.2% to Rs 20,091 million during FY24.

The current Price to earnings ratio of ERIS LIFESCIENCES, based on rolling 12 month earnings, stands at 47.5.


Equitymaster requests your view! Post a comment on "ERIS LIFESCIENCES Gains 5%; BSE HEALTHCARE Index Down 0.3%". Click here!